Adage Capital Partners’s Rapid Micro Biosystems RPID Stock Holding History

Adage Capital Partners’s Portfolio RPID Stock Details RPID Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-700,000	Closed	-$518K	–	940
2023 Q4	$518K	Hold	700,000	–	–	﹤0.01%	782
2023 Q3	$756K	Hold	700,000	–	–	﹤0.01%	772
2023 Q2	$700K	Hold	700,000	–	–	﹤0.01%	774
2023 Q1	$917K	Sell	700,000 -16,209	-2%	-$21.1K	﹤0.01%	799
2022 Q4	$809K	Hold	716,209	–	–	﹤0.01%	850
2022 Q3	$2.31M	Sell	716,209 -33,791	-5%	-$131K	0.01%	846
2022 Q2	$3.23M	Buy	750,000 +50,000	+7%	+$233K	0.01%	849
2022 Q1	$4.75M	Buy	700,000 +118,757	+20%	+$875K	0.01%	836
2021 Q4	$6.18M	Sell	581,243 -135,423	-19%	-$2.11M	0.01%	793
2021 Q3	$13.2M	Buy	+716,666	New	+$14.8M	0.03%	609

Other funds holding RPID

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

KLM

Kennedy Lewis Management New York $21.9M AUM 12.46% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AWGLSCP

ABG-WTT Global Life Science Capital Partners Central, Hong Kong, Hong Kong $12.3M AUM 3.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Adage Capital Partners's RPID Position: Q1 2024 in Review

Adage Capital Partners sold out of Rapid Micro Biosystems (RPID) in Q1 2024, closing a stake of 700,000 shares — an estimated $518K sold.

Adage Capital Partners first reported a position in RPID in Q3 2021 and held it in 10 quarters. The position peaked at $13.2M in Q3 2021. 23 funds tracked by Wall St. Rank hold RPID as of Q1 2024.

Adage Capital Partners reported no remaining Rapid Micro Biosystems position as of Q1 2024 after selling out during the quarter.
Adage Capital Partners sold 700,000 Rapid Micro Biosystems shares in Q1 2024, an estimated $518K.
Adage Capital Partners first reported a position in Rapid Micro Biosystems in Q3 2021 and held it in 10 quarters.
Adage Capital Partners's Rapid Micro Biosystems position peaked at $13.2M in Q3 2021.
23 funds tracked by Wall St. Rank held Rapid Micro Biosystems as of Q1 2024.

Based on Adage Capital Partners's 13F filing for Q1 2024, filed 15 May 2024.